There are 807 resources available
Why and how may antibody drug conjugates make rapid moves to earlier disease phases
Presenter: Sherene Loi
Session: Antibody drug conjugates (ADCs) and breast cancer: Achievements and prospects
Resources:
Slides
Webcast
178O - Rucaparib maintenance treatment in patients (pts) with newly diagnosed ovarian cancer (OC): Defining benefit according to disease risk subgroups within the phase III ATHENA–MONO study
Presenter: Keiichi Fujiwara
Session: Proffered Paper session: Gynaecological tumours
Resources:
Abstract
Slides
Webcast
72MO - Clinical outcomes and response (R) with atezolizumab plus bevacizumab (AB) or lenvatinib (L) in hepatocellular carcinoma (HCC)
Presenter: Mara Persano
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
Radiation therapy of the primary tumour plus/minus SBRT of the metastatic lesions
Presenter: Katsumsa Nakamura
Session: Synchronous oligometastatic prostate cancer based on PSMA PET imaging
Resources:
Slides
Webcast
Radiation oncologist’s perspective
Presenter: Cécile Le Pechoux
Session: Optimal treatment approach of stage IIIa: Oncogenic vs non-oncogenic driven
Resources:
Slides
Webcast
Gender-related challenges in India
Presenter: Jyoti Bajpai
Session: Gender balance in oncology: Perspectives from Asia – with ESMO W4O
Resources:
Slides
Webcast
Q&A and discussion
Presenter: Sherene Loi
Session: Antibody drug conjugates (ADCs) and breast cancer: Achievements and prospects
Resources:
Slides
Webcast
Invited Discussant 176O, 177O and 178O
Presenter: Michael Friedlander
Session: Proffered Paper session: Gynaecological tumours
Resources:
Slides
Webcast
LBA2 - Tislelizumab (TIS) versus sorafenib (SOR) in first-line (1L) treatment of unresectable hepatocellular carcinoma (HCC): The RATIONALE-301 Chinese subpopulation analysis
Presenter: Shukui Qin
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
Surgical approach in patients with synchronous oligometastastic prostate cancer based on PSMA PET imaging
Presenter: Masatoshi Eto
Session: Synchronous oligometastatic prostate cancer based on PSMA PET imaging
Resources:
Slides
Webcast